Skip to main content

Csenge Advisory Group

SEC CIK
0001715593
Latest filing
Aug 10, 2026

PFE holding history

Pfizer Inc in every 13F filed by Csenge Advisory Group, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PFE overviewAll 13F holders of PFEFull Q2 2026 holdings

Shares (Q2 2026)
154,984
Value
$3.73M
% of portfolio
0.2%
Quarters held
22
Since Q1 2021
Holdings of PFE by Csenge Advisory Group, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026154,984$3.73M0.2%+4,774+3.2%AddedHolders
Q1 2026150,210$4.22M0.2%−2,180−1.4%ReducedHolders
Q4 2025152,390$3.79M0.2%+15,809+11.6%AddedHolders
Q3 2025136,581$3.48M0.2%+48,137+54.4%AddedHolders
Q2 202588,444$2.08M0.1%+4,175+5.0%AddedHolders
Q1 202584,269$1.87M0.1%+45,214+115.8%AddedHolders
Q4 202439,055$1.04M0.1%−6,518−14.3%ReducedHolders
Q3 202445,573$1.33M0.1%−1,327−2.8%ReducedHolders
Q2 202446,900$1.31M0.1%+1,305+2.9%AddedHolders
Q1 202445,595$1.27M0.1%−3,370−6.9%ReducedHolders
Q4 202348,965$1.41M0.1%−11,360−18.8%ReducedHolders
Q3 202360,325$2.00M0.1%+4,208+7.5%AddedHolders
Q2 202356,117$2.06M0.1%−1,196−2.1%ReducedHolders
Q1 202357,313$2.34M0.2%−78−0.1%ReducedHolders
Q4 202257,391$2.94M0.2%+178+0.3%AddedHolders
Q3 202257,213$2.50M0.2%−3,291−5.4%ReducedHolders
Q2 202260,504$3.17M0.3%+6,995+13.1%AddedHolders
Q1 202253,509$2.77M0.2%+3,876+7.8%AddedHolders
Q4 202149,633$1.96M0.2%+6,450+14.9%AddedHolders
Q3 202143,183$1.85M0.2%−6,450−13.0%ReducedHolders
Q2 202149,633$1.96M0.2%+20,529+70.5%AddedHolders
Q1 202129,104$1.06M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.